Stockreport

Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy

Biomerica, Inc.  (BMRA) 
NASDAQ:AMEX Investor Relations: biomerica.com/company/investor.asp
PDF Key Highlights Responder Analysis: 59.4% of patients achieved =30% reduction in abdominal pain; 68.1% achieved =30% reduction in bloating—using the FDA-recognized r [Read more]